Rivastigmine–Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases

With the goal of combating the multi-faceted Alzheimer’s disease (AD), a series of Rivastigmine-Benzimidazole (RIV–BIM) hybrids was recently reported by us as multitarget-directed ligands, thanks to their capacity to tackle important hallmarks of AD. In particular, they exhibited antioxidant activit...

Descripción completa

Detalles Bibliográficos
Autores principales: Vicente-Zurdo, David, Brunetti, Leonardo, Piemontese, Luca, Guedes, Beatriz, Cardoso, Sandra M., Chavarria, Daniel, Borges, Fernanda, Madrid, Yolanda, Chaves, Sílvia, Santos, M. Amélia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179505/
https://www.ncbi.nlm.nih.gov/pubmed/37176018
http://dx.doi.org/10.3390/ijms24098312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179505/
https://www.ncbi.nlm.nih.gov/pubmed/37176018
http://dx.doi.org/10.3390/ijms24098312

Ejemplares similares